Sentinel node and early breast cancer; identification by blue dye injection. Pilot study;Ganglion sentinelle et cancer opérable du sein: Utilisation du bleu patent. Étude pilote

Annales de Chirurgie

Volumn 125, Issue 3, 2000, Pages 253-258

  Salmon, R J ^a   Nos, C ^a   Lojodice, F ^a   Languille, O ^a   Remvikos, Y ^a   Vilcoq, J R ^a   Clough, K B ^a  

^a INSTITUT CURIE   (France)

Author keywords

Blue dye; Breast cancer; Sentinel node

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; BLUE DYE; DYE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; INJECTION; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PILOT STUDY; SENSITIVITY AND SPECIFICITY; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER SIZE; DIAGNOSTIC ACCURACY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE; STAINING;

ADULT; AGED; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY;

EID: 0034167659     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-4001(00)00139-2     Document Type: Article

References (22)

1. Salmon R.J., Asselain B., Le Gal M., Fourquet A., the Institut Curie «Breast Group». Twelve years experience of breast cancer at the Institute Curie; improvement of survival and value of screening mammographies. Breast. 6:1997;202-205.
2. Chadha M., Chabon A.B., Friedmann P., Vitkam B. Predictors of axillary lymph nodes metastases in patients with T1 breast cancer. A multivariate analysis. Cancer. 73:1994;350.
3. Lin P., Allison D., Wainstuck J., Miller K.D., Dooley W.C., Friedman N. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol. 11:1993;1536.
4. Axelsson C., Mouridssen H., Zedelek K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer. 28A:1992;1415.
5. Kinne D. Impact of local regional therapy on breast cancer survival. Ann Surg Oncol. 6:1999;420-421.
6. Krag P.N., Weaver D.L., Alex J.C. Surgical resection and radiolocalisation of the sentinel node in breast cancer using a gamma probe. Ann Surg Oncol. 2:1993;335-340.
7. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-401.
8. Linehan D.C., Hill D.K., Akhurst T., Yeung H., Yeh S.D.J., Tran K.N., et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol. 6:1999;450-454.
9. Bland K.I. Refining the optimal technical approach for sentinel node localisation in breast cancer patients. Ann Surg Oncol. 6:1999;418-419.
10. Salmon R.J., Nos C., Clough K.B. Le ganglion sentinelle dans les cancers opérables du sein. Chirurgie. 124:1999;435-440.
11. Giuliano A.E. See one, do twenty-five, teach once: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol. 124:1999;520-521.
12. Krag D.N., Weaver D.L., Ashikaga T., Moffat F., Klimberg V.S., Shriver C., et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J M. 339:1998;941-946.
13. Nos C., Bourgeois D., Freneaux P., Zafrani B., Salmon R.J., Clough K.B. Individualisation du ganglion sentinelle en cas de cancer du sein. Expérience de l'Institut Curie. Bull Cancer. 86:1999;580-584.
14. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurida S., Mdedoni, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet. 349:1997;1864-1867.
15. Rodier J.F., Routiot T., Mignotte H., Janser J.C., Bremond A., Barlier C., et al. Individualisation du ganglion axillaire sentinelle par colorant lymphotrope dans les cancers du sein: étude de faisabilité à propos de 128 cas. Chirurgie. 123:1998;239-246.
16. Rubio I.T., Kourourian S., Cowan C., Krag D.N., Colvert M., Klimberg V.S. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol. 5:1998;689-694.
17. Reicher R.A. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol. 6:1999;513.
18. Tafra L., Chua A.N., Ng P.C., Aycock D., Swanson M., Lannin D. Filtered versus unfiltered technetium sulfur colloid in lymphatic mapping: a significant variable in a pig model. Ann Surg Oncol. 6:1999;83-87.
19. Nathanson S.D., Anaya P., Karvelis P.C., Eck L., Havstad S. Sentinel node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol. 4:1997;104-110.
20. Cote R.J., Peterson H.F., Chaiwun B., Gelber R.D., Goldhirsch A., Castiglione, et al. for the International Breast Cancer Study Group. Role of immunihistochemical detection of lymph node metastases in management of breast cancer. Lancet. 354:1999;896-900.
21. Cox C.E., Bass S.S., Boulware D., Ku N.K., Berman C., Reintgen D.S. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol. 6:1999;553-561.
22. Copeland E.M. A plea for the pathologically accurate sentinel node. Ann Surg Oncol. 6:1999;522-523.